Rechallenge with pemetrexed-based chemotherapy improves the survival of patients with advanced non-squamous non-small-cell lung cancer

Rechallenge chemotherapy with pemetrexed was shown to be efficient in malignant pleural mesothelioma; however, its role in non-small-cell lung cancer (NSCLC) has not been investigated. In this study, we retrospectively enrolled 31 patients with non-squamous NSCLC who had achieved disease control wit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: ZHUO, MING-LEI, BAI, HUA, WANG, ZHI-JIE, DUAN, JIAN-CHUN, AN, TONG-TONG, WU, MEI-NA, ZHAO, JUN, WANG, YU-YAN, WANG, SHU-HANG, WANG, JIE
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2014
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4179803/
https://ncbi.nlm.nih.gov/pubmed/25279180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.359
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars